This page is part of the Clinical Guidelines (v1.0.0: STU 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Label | Item | Description | Item Status | Notes |
---|---|---|---|---|
1. | Guideline Content (L1) | Complete L1 content and documentation for the guideline | ||
1.a | Permalink | Permanent URL for the guideline content, if available | ||
1.b | Citation | Appropriately formatted citation for the guideline | Required | |
1.c | Status | Current status of the guideline, including last reviewed, endorsing parties, and timeline of pending changes | Required | |
1.d | Contact | Contact information for the guideline developer and steward | Required | |
1.d.i | Guideline Developer | Direct contact for guideline developer | ||
1.d.ii | Content/Guideline Steward Contact | Public contact information for the guideline steward | ||
2. | Legal & Licensing | All legal and licensing issues are addressed | ||
2.a | Guideline licensing terms | What are the licensing terms for the use of the guideline | Required | |
2.b | Content licensing terms | What will the licensing terms for the L2 and L3 artifacts be | Required | |
2.c | Additional licensing terms | What additional content licensing is required, if any | Required | |
3. | Scope | Clearly determine the overall scope of the project | ||
3.a | Goal(s) | What goal(s) is the recommendation trying to achieve? | ||
3.b | Target Recommendations | What recommendations are targeted for the project | Required | |
3.c | Per Recommendation | For each recommendation, ensure the following | This is a header, not an item to check off | |
3.c.i | GuideLine Implementability Appraisal (GLIA) checklist | A GLIA checklist is provided | Although it was designed for end-users who are deciding whether to adopt a (hard-copy) GL, several of the elements in GLIA are worth consideration by all work streams for L2-L4. One sub-element for L4 might be “usability”. How facile is the end-product to navigate and use? | |
3.c.ii | Triggering | How will the recommendation be triggered? | ||
3.c.ii.1 | Terminologies | What terminologies are involved? | ||
3.c.ii.2 | Clinical State | What clinical states are involved? | ||
3.c.ii.3 | Setting | What settings or environments are relevant? | ||
3.c.ii.4 | Periodic | How often should the recommendation be triggered/reviewed? | ||
3.c.iii | Condition | How will the condition be expressed? | ||
3.c.iii.1 | Terminologies | What terminologies are involved? | ||
3.c.iii.2 | Clinical State | What clinical states are involved? | ||
3.c.iv | Action | How will the action be expressed? | Required | |
3.c.iv.1 | Request/Order | What orderables are involved? | Required | |
3.c.iv.2 | Assessment | What instruments are involved? | Required | |
3.c.iv.3 | Questionnaire | What questionnaires are involved? | Required | |
3.c.v | Monitoring | How will the recommendation be assessed/monitored? | ||
3.c.v.1 | Measures | What measures are available/appropriate? | Define thresholds related to goal(s) | |
3.c.v.2 | Performance Measures | What measures are looking at the aspects related to the clinical condition? | ||
3.c.v.3 | Process Measures | What measures are looking at the aspects related to CDS workflow and feasibility | Implementation Team should consider | |
3.c.v.4 | Outcome Measures | What measures are looking at the aspects related to the health of the patient | ||
3.c.v.5 | Guideline Evaluation Metrics | What measures are looking at how well the recommendation is meeting its goal(s)? | ||
3.c.vi | Use Case | A clear description of a use case for the recommendation | Required | |
3.c.vii | Diagram/ workflow diagram | A visual depiction of the workflow for the recommendation | ||
3.c.viii | Test Plan | A description of the testing plan | ||
4. | Existing Artifacts | What existing artifacts are available, either wholesale, or for derivation and reuse? | ||
4.a | Terminologies | What value sets are available? | ||
4.a.i | Existing | What value sets exist? Can they be reused or do they need modification/augmentation? | ||
4.a.ii | Need to be created | What value sets need to be created? | ||
4.b | Assessments | What formal instruments are available? Can they be reused? | ||
4.c | Questionnaires | What questionnaires are available? | ||
4.d | Profiles | What profiles are available? | ||
4.e | PlanDefinition/ActivityDefinition | What definitions are already available? | ||
4.f | Libraries | What libraries are available? | ||
4.g | Test Data | What test data is available? What test data generation facilities are available? | ||
4.h | Decision Aids | What aids are available that help patients make decisions or can be used for shared decision-making? | ||
5. | Publication Strategy | What publication strategy will be used for the L2/L3 content? | ||
5.a | Target Repository | What publication channel will be used? (e.g. FHIR Registry, CDS Connect) | ||
5.b | Project Repository | Set up a project repository and collaboration wiki | ||
5.c | Publishing URL | Establish a base URL for the content | ||
5.d | Terminology Publication Strategy | Where will the terminologies be published? (e.g. FHIR Registry, Simplifier, VSAC, PHINVADS) | ||
6. | Stewarding and Maintenance | How will the content be maintained over time? | ||
6.a | Change Management | What external dependencies will impact the content? Document change sources and timelines | ||
6.b | L2 Steward | Who will maintain the content long term? | Required | |
6.c | Strategy | What is the strategy for reacting to changes? | ||
7. | Piloting | Who will pilot the content as part of the development process? | ||
7.a | Pilot Site(s) | Identify at least one primary pilot site (alpha) and potentially second phase (beta) sites. | ||
7.b | Pilot Team Members | Engage pilot site members as part of the development team | ||
8 | System Feedback | |||
8a. | SDO Feedback | Are there gaps in the specifications being used that would trigger feedback to an appropriate SDO? | ||
8b. | Policy | Are there problems in a policies that would trigger feedback to the policy owner? | ||
9 | Case Reporting | Is there a potential need for monitoring disease trends or outbreak management? | Required by law for clinicians to report certain conditions to the appropriate public health agency/jurisdiction | |
9.a. | Existing Artifacts | HL7 CDA for initial case report, and CDA for reportability response (currently published); working on case reporting standards - FHIR: knowledge distribution (plan def, trigger codes), eICR, trigger codes |